Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
DUBLIN, Oct. 22, 2025 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“...
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.

Online Support GroupsFree, online support groups worldwide for people with Narcolepsy and their families. |


National SummitThis one-day summit is for people with Narcolepsy, their families, educators, clinicians and researchers. |

Clinical TrialsPatient engagement in clinical trials help find new ways to treat individuals with Narcolepsy. |

Annual Family WeekendChildren & Teens with Narcolepsy can meet others experiencing the same symptoms and challenges. |

Join Our TeamDo you share our passion for advocating on behalf of those with Narcolepsy? |
DUBLIN, Oct. 22, 2025 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“...
Join us on November 12th at 2pm ET for our next Brown Bag Webinar, “Navigating......
The inaugural Wake Up Narcolepsy (WUN) Bridging Perspectives Convening took place on September 26th at......
Back in August, Wake Up Narcolepsy (WUN) announced the second year of Worldwide Step Up For......